Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-13 Sale |
2025-01-15 5:00 pm |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
43,804 | $1.2632 | $55,333 | 45,478 (Direct) |
View |
| 2024-01-18 Sale |
2024-01-18 8:24 pm |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
5,468 | $1.1906 | $6,510 | 5,782 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-30 Option Award |
2025-01-31 5:00 pm |
N/A 2035-01-29 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
562,500 | $0 | 562,500 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
21,000 | $1.3 | 89,282 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-10 5:00 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
62,500 | $1.36 | 89,282 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-21 4:21 pm |
N/A 2034-05-19 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
462,000 | $0 | 462,000 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 5:08 pm |
N/A 2034-01-11 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
96,250 | $0 | 96,250 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:19 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
375,000 | $0 | 375,000 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-17 4:10 pm |
N/A 2033-01-10 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-11 4:34 pm |
N/A 2030-01-20 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-26 4:12 pm |
N/A 2032-01-11 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
480,000 | $0 | 480,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:58 pm |
N/A 2031-02-04 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |